Research advances in improving drug efficacy through remodeling of tumor vascular function by different aerobic exercises
Open Access
- 8 April 2026
- journal article
- Published by Frontiers Media SA in Frontiers in Sports and Active Living
- Vol. 8
Abstract
Structural and functional abnormalities of tumor vasculature are key factors limiting drug delivery and therapeutic efficacy. This review aims to systematically summarize the mechanisms and evidence regarding how aerobic exercise improves drug delivery and enhances tumor treatment response by remodeling tumor vascular function. By synthesizing recent studies, we summarize the effects of different aerobic exercise modalities (intensity, duration, frequency) on tumor vasculature and the synergistic effects of combining exercise with pharmacotherapy. Aerobic exercise can increase pericyte coverage and enhance vascular stability, reduce vascular permeability and tumor interstitial fluid pressure (IFP) to improve drug penetration, enhance tumor blood flow perfusion and oxygenation to alleviate the hypoxic microenvironment, and modulate tumor metabolism and acid-base balance. These effects collectively promote the distribution and accumulation of drugs within tumor tissue, thereby enhancing treatment efficacy. The effects of exercise are influenced by its intensity, duration, frequency, and tumor type, with moderate-intensity, regular regimens (e.g., 3–5 times per week) being the most substantiated. Aerobic exercise serves as an effective non-pharmacological adjuvant that can significantly improve drug delivery and enhance anti-tumor treatment outcomes through multi-dimensional remodeling of tumor vascular function and the tumor microenvironment. Future prospective clinical studies, incorporating imaging and molecular biomarkers, are needed to further define optimal exercise protocols and their role in individualized integrated cancer therapy.Keywords
This publication has 72 references indexed in Scilit:
- Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive‐stage small‐cell lung cancer: Results of two prospective phase II studiesInternational Journal of Cancer, 2025
- Advances in tumor vascular growth inhibitionClinical and Translational Oncology, 2024
- Targeting tumor vascularization: promising strategies for vascular normalizationJournal of Cancer Research and Clinical Oncology, 2021
- Angiogenesis as a hallmark of solid tumors - clinical perspectivesCellular Oncology, 2021
- Hyperthermia and smart drug delivery systems for solid tumor therapyAdvanced Drug Delivery Reviews, 2020
- Tumor angiogenesis: causes, consequences, challenges and opportunitiesCellular and Molecular Life Sciences, 2019
- Vascular modulation through exercise improves chemotherapy efficacy in Ewing sarcomaPediatric Blood & Cancer, 2019
- Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancerSupportive Care in Cancer, 2016
- Exercise regulates breast cancer cell viability: systemic training adaptations versus acute exercise responsesBreast Cancer Research and Treatment, 2016
- Extracellular pressure stimulates colon cancer cell adhesion in vitro and to surgical wounds by Src (sarcoma protein) activationThe American Journal of Surgery, 2004